Senior Vice President, Chief Operating Officer R&D
As Senior Vice President, Chief Operating Officer R&D, Dr. Nicholas Donoghoe leads the operational and strategic advancement of AbbVie’s pipeline. He oversees Clinical Development Operations (CDO), Transformation/Innovation and Health Economics and Outcomes Research (HEOR) to deliver remarkable therapies to our patients globally. Additionally, Dr. Donoghoe leads Search and Evaluation, Business Development and Acquisitions, Global Alliances and Corporate Strategy in the establishment of strategy and partnerships across the development continuum that will benefit patients and fuel scientific progress.
Dr. Donoghoe previously held leadership roles across R&D and Commercial, in both AbbVie’s Therapeutic and Aesthetic businesses. He was a partner at McKinsey & Co and has an M.D. from Johns Hopkins School of Medicine.
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?